{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:22:00Z","timestamp":1790050920777,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017018","name":"Wallenberg Centre for Molecular and Translational Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejso.2021.11.010","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T21:03:40Z","timestamp":1636491820000},"page":"320-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary"],"prefix":"10.1016","volume":"48","author":[{"given":"I.","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.","family":"Dwarkasing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rentroia-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Olofsson Bagge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejso.2021.11.010_bib1","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ijc.31141","article-title":"Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014","volume":"142","author":"Aitken","year":"2018","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2021.11.010_bib2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/bjd.13483","article-title":"Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men","volume":"172","author":"Lyth","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.ejso.2021.11.010_bib3","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA A Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ejso.2021.11.010_bib4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1245\/s10434-017-6267-7","article-title":"Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American society of clinical oncology and society of surgical oncology clinical practice guideline update","volume":"25","author":"Wong","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2021.11.010_bib5","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1245\/s10434-011-2095-3","article-title":"The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival","volume":"19","author":"Baehner","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2021.11.010_bib6","series-title":"1992. Crit rev oncog","first-page":"7","article-title":"Sentinel Lymph Node Biopsy: evolution of the Technique Since the Original Description by Morton et\u00a0al","volume":"vol. 21","author":"Uren","year":"2016"},{"issue":"6","key":"10.1016\/j.ejso.2021.11.010_bib7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.ejso.2021.11.010_bib8","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ejso.2021.11.010_bib9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"32","key":"10.1016\/j.ejso.2021.11.010_bib10","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.18.02306","article-title":"Final analysis of DeCOG-SLT trial: No survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node","volume":"37","author":"Leiter","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2021.11.010_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/jso.25208","article-title":"Sentinel lymph node biopsy in patients with thin melanomas: frequency and predictors of metastasis based on analysis of two large international cohorts","volume":"118","author":"Isaksson","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2021.11.010_bib12","series-title":"ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee","author":"Michielin","year":"2020"},{"issue":"9","key":"10.1016\/j.ejso.2021.11.010_bib13","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/ans.15358","article-title":"Sentinel lymph node biopsy in patients with malignant melanoma: analysis of post-operative complications","volume":"89","author":"Solari","year":"2019","journal-title":"ANZ J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2021.11.010_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/CMR.0b013e3282f2017d","article-title":"Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection","volume":"18","author":"Kretschmer","year":"2008","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejso.2021.11.010_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejca.2017.07.052","article-title":"Health-related quality of life in melanoma patients: impact of melanoma-related limb lymphoedema","volume":"85","author":"Gjorup","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2021.11.010_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejca.2019.11.014","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics - Update 2019","volume":"126","author":"Garbe","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2021.11.010_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejca.2019.11.015","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment - Update 2019","volume":"126","author":"Garbe","year":"2020","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2021.11.010_bib18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.annonc.2020.07.005","article-title":"ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee","volume":"31","author":"Michielin","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2021.11.010_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1200\/PO.19.00206","article-title":"Model combining tumor molecular and clinicopathologic risk factors predicts sentinel lymph node metastasis in primary cutaneous melanoma","volume":"4","author":"Bellomo","year":"2020","journal-title":"JCO Precis Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2021.11.010_bib20","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/bjd.19499","article-title":"Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma","volume":"184","author":"Mulder","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejso.2021.11.010_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2020.08.029","article-title":"Identification of stage I\/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model","volume":"140","author":"Eggermont","year":"2020","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321008143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321008143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:41:06Z","timestamp":1760060466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798321008143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0748798321008143"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2021.11.010","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2021.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}